IRIS Accounts Production v26.3.0.614 11152125 director 1.2.25 31.1.26 31.1.26 false true false false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh111521252025-01-31111521252026-01-31111521252025-02-012026-01-31111521252024-01-31111521252024-02-012025-01-31111521252025-01-3111152125ns15:EnglandWales2025-02-012026-01-3111152125ns14:PoundSterling2025-02-012026-01-3111152125ns10:Director12025-02-012026-01-3111152125ns10:PrivateLimitedCompanyLtd2025-02-012026-01-3111152125ns10:SmallEntities2025-02-012026-01-3111152125ns10:AuditExempt-NoAccountantsReport2025-02-012026-01-3111152125ns10:SmallCompaniesRegimeForDirectorsReport2025-02-012026-01-3111152125ns10:SmallCompaniesRegimeForAccounts2025-02-012026-01-3111152125ns10:FullAccounts2025-02-012026-01-311115212512025-02-012026-01-3111152125ns10:RegisteredOffice2025-02-012026-01-3111152125ns5:CurrentFinancialInstruments2026-01-3111152125ns5:CurrentFinancialInstruments2025-01-3111152125ns5:Non-currentFinancialInstruments2026-01-3111152125ns5:Non-currentFinancialInstruments2025-01-3111152125ns5:ShareCapital2026-01-3111152125ns5:ShareCapital2025-01-3111152125ns5:RevaluationReserve2026-01-3111152125ns5:RevaluationReserve2025-01-3111152125ns5:RetainedEarningsAccumulatedLosses2026-01-3111152125ns5:RetainedEarningsAccumulatedLosses2025-01-3111152125ns5:NetGoodwill2025-02-012026-01-3111152125ns5:IntangibleAssetsOtherThanGoodwill2025-02-012026-01-3111152125ns5:LandBuildings2025-02-012026-01-3111152125ns5:PlantMachinery2025-02-012026-01-3111152125ns5:NetGoodwill2025-01-3111152125ns5:NetGoodwill2026-01-3111152125ns5:NetGoodwill2025-01-3111152125ns5:LandBuildings2025-01-3111152125ns5:PlantMachinery2025-01-3111152125ns5:LandBuildings2026-01-3111152125ns5:PlantMachinery2026-01-3111152125ns5:LandBuildings2025-01-3111152125ns5:PlantMachinery2025-01-3111152125ns5:CostValuation2025-01-3111152125ns5:WithinOneYearns5:CurrentFinancialInstruments2026-01-3111152125ns5:WithinOneYearns5:CurrentFinancialInstruments2025-01-3111152125ns5:Secured2026-01-3111152125ns5:Secured2025-01-3111152125ns5:RevaluationReserve2025-01-31
REGISTERED NUMBER: 11152125 (England and Wales)















Financial Statements For The Year Ended 31st January 2026

for

Kent Equine Hospital Limited

Kent Equine Hospital Limited (Registered number: 11152125)

Contents of the Financial Statements
For The Year Ended 31st January 2026










Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


Kent Equine Hospital Limited

Company Information
For The Year Ended 31st January 2026







DIRECTOR: Ms K L Snalune





REGISTERED OFFICE: 1-3 Manor Road
Chatham
Kent
ME4 6AE





REGISTERED NUMBER: 11152125 (England and Wales)





ACCOUNTANTS: Beak Kemmenoe
Chartered Accountants
1-3 Manor Road
Chatham
Kent
ME4 6AE

Kent Equine Hospital Limited (Registered number: 11152125)

Balance Sheet
31st January 2026

2026 2025
Notes £    £    £    £   
FIXED ASSETS
Intangible assets 4 1,667 7,287
Tangible assets 5 1,319,680 1,468,767
Investments 6 243,590 243,590
1,564,937 1,719,644

CURRENT ASSETS
Stocks 50,700 37,918
Debtors 7 91,190 61,679
Cash at bank and in hand 89 1,906
141,979 101,503
CREDITORS
Amounts falling due within one year 8 600,513 512,024
NET CURRENT LIABILITIES (458,534 ) (410,521 )
TOTAL ASSETS LESS CURRENT
LIABILITIES

1,106,403

1,309,123

CREDITORS
Amounts falling due after more than one
year

9

1,428,509

1,576,672
NET LIABILITIES (322,106 ) (267,549 )

CAPITAL AND RESERVES
Called up share capital 10 10
Revaluation reserve 11 50,717 50,717
Retained earnings (372,833 ) (318,276 )
SHAREHOLDERS' FUNDS (322,106 ) (267,549 )

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31st January 2026.

The members have not required the company to obtain an audit of its financial statements for the year ended 31st January 2026 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges her responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

Kent Equine Hospital Limited (Registered number: 11152125)

Balance Sheet - continued
31st January 2026


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the director and authorised for issue on 27th October 2026 and were signed by:





Ms K L Snalune - Director


Kent Equine Hospital Limited (Registered number: 11152125)

Notes to the Financial Statements
For The Year Ended 31st January 2026


1. STATUTORY INFORMATION

Kent Equine Hospital Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention as modified by the revaluation of certain assets.

Preparation of consolidated financial statements
The financial statements contain information about Kent Equine Hospital Limited as an individual company and do not contain consolidated financial information as the parent of a group. The company is exempt under Section 399(2A) of the Companies Act 2006 from the requirements to prepare consolidated financial statements.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Goodwill
Goodwill, being the amount paid in connection with the acquisition of a business in 2018, is being amortised evenly over its estimated useful life of eight years.

Intangible assets
Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Land and buildings - 10% on reducing balance
Plant and machinery etc - 25% on reducing balance

Investments in subsidiaries
Investments in subsidiary undertakings are recognised at cost.

Stocks
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.


Kent Equine Hospital Limited (Registered number: 11152125)

Notes to the Financial Statements - continued
For The Year Ended 31st January 2026


2. ACCOUNTING POLICIES - continued
Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Hire purchase and leasing commitments
Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 10 (2025 - 10 ) .

4. INTANGIBLE FIXED ASSETS
Goodwill
£   
COST
At 1st February 2025
and 31st January 2026 44,960
AMORTISATION
At 1st February 2025 37,673
Charge for year 5,620
At 31st January 2026 43,293
NET BOOK VALUE
At 31st January 2026 1,667
At 31st January 2025 7,287

Kent Equine Hospital Limited (Registered number: 11152125)

Notes to the Financial Statements - continued
For The Year Ended 31st January 2026


5. TANGIBLE FIXED ASSETS
Plant and
Land and machinery
buildings etc Totals
£    £    £   
COST OR VALUATION
At 1st February 2025 1,488,864 401,728 1,890,592
Additions - 8,971 8,971
At 31st January 2026 1,488,864 410,699 1,899,563
DEPRECIATION
At 1st February 2025 184,613 237,212 421,825
Charge for year 114,686 43,372 158,058
At 31st January 2026 299,299 280,584 579,883
NET BOOK VALUE
At 31st January 2026 1,189,565 130,115 1,319,680
At 31st January 2025 1,304,251 164,516 1,468,767

Cost or valuation at 31st January 2026 is represented by:

Plant and
Land and machinery
buildings etc Totals
£    £    £   
Valuation in 2023 50,717 - 50,717
Cost 1,438,147 410,699 1,848,846
1,488,864 410,699 1,899,563

If freehold land and buildings had not been revalued they would have been included at the following historical cost:

2026 2025
£    £   
Cost 1,488,864 1,433,123

Value of land in freehold land and buildings 180,000 180,000

Freehold land and buildings were valued on an open market basis on 31st January 2025 by the director .

Kent Equine Hospital Limited (Registered number: 11152125)

Notes to the Financial Statements - continued
For The Year Ended 31st January 2026


6. FIXED ASSET INVESTMENTS
Shares in
group
undertakings
£   
COST
At 1st February 2025
and 31st January 2026 243,590
NET BOOK VALUE
At 31st January 2026 243,590
At 31st January 2025 243,590

7. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2026 2025
£    £   
Trade debtors 42,548 8,069
Other debtors 48,642 53,610
91,190 61,679

8. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2026 2025
£    £   
Bank loans and overdrafts 107,823 171,067
Hire purchase contracts 9,504 9,981
Trade creditors 137,537 141,368
Taxation and social security 104,169 133,166
Other creditors 241,480 56,442
600,513 512,024

9. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE
YEAR
2026 2025
£    £   
Bank loans 8,431 76,713
Hire purchase contracts 9,578 19,082
Other creditors 1,410,500 1,480,877
1,428,509 1,576,672

Kent Equine Hospital Limited (Registered number: 11152125)

Notes to the Financial Statements - continued
For The Year Ended 31st January 2026


10. SECURED DEBTS

The following secured debts are included within creditors:

2026 2025
£    £   
Bank loans 19,239 151,672
Hire purchase contracts 19,082 29,063
38,321 180,735

Assets held on hire purchase are secured on the assets concerned.

The Kent County Council have a fixed charge over the freehold property.

Folk Nominee Limited have a fixed and floating charge over the assets of the company.

11. RESERVES
Revaluation
reserve
£   
At 1st February 2025
and 31st January 2026 50,717